Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.inogen.com

Address:

859 Ward Drive, Goleta, United States

JarvisFlow Jun. 16 at 5:32 PM

B. Riley Securities has updated their rating for Inogen ( $INGN ) to Buy with a price target of 14.

0 · Reply

ZacksResearch May. 28 at 2:50 PM

Is $INGN set for a rebound? 📈 Despite a 21.4% decline so far this year, Inogen's strong Q1 results and attractive P/S ratio of 0.6X vs. the industry's 2.6X show promise. The Zacks Rank #2 stock also projects 7.2% earnings growth for 2025, with continued momentum in the POC space. See why this could be a buying opportunity 👉 https://www.zacks.com/commentary/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-body&ADID=SYND_STOCKTWITS_TWEET_2_2478116_BODY

0 · Reply

ZacksResearch May. 28 at 12:47 PM

Expanding product portfolio and high prospects for POC raise optimism for $INGN stock. Explore further: https://www.zacks.com/stock/news/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478116_TEASER

0 · Reply

MoneyTree82 May. 27 at 2:38 PM

$INGN only 26 million share with improving revenues 💪

0 · Reply

ZacksResearch May. 27 at 1:12 PM

Broker upgrades boost $URBN, $INGN and $SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility. Here's more: https://www.zacks.com/stock/news/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477604_TEASER

0 · Reply

ZacksResearch May. 27 at 12:12 PM

Trade war jitters or a buying opportunity? Here's why $URBN, $INGN & $SWX might shine! 🚀 ✅ Urban Outfitters: Fiscal 2026 earnings to rise 20% with a 9.1% broker rating upgrade. ✅ Inogen: 2025 earnings projected to grow 24.3%, broker ratings up 25%. ✅ Southwest Gas: 2025 earnings expected to increase 18.4%, with a 14.3% broker rating boost. Discover the full potential here 👉 https://www.zacks.com/commentary/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-body&ADID=SYND_STOCKTWITS_TWEET_2_2477604_BODY

0 · Reply

RunnerSignals May. 22 at 9:39 PM

Fresh Upgrades and Downgrades After-Hours! $CR $INGN $GRFS $MU $SWK and more in play! Analysts reshuffled the deck - who's your pick going into Friday? stocksrunner.com/news/2025-05-22-thursday-analyst-upgrades-and-downgrades

0 · Reply

Thestocktraderhubzee May. 22 at 4:02 PM

$INGN Inogen shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $12 price target.

0 · Reply

erevnon May. 22 at 11:22 AM

Needham upgrades Inogen $INGN from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow May. 22 at 10:30 AM

Needham updates rating for Inogen ( $INGN ) to Buy, target set at 12.

0 · Reply

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 5 weeks ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 5 weeks ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 3 months ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 3 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 3 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 3 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 3 months ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 4 months ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 5 months ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 5 months ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 5 months ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 6 months ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 7 months ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 7 months ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 8 months ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 8 months ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 8 months ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 10 months ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 11 months ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 11 months ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 1 year ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 1 year ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 1 year ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 1 year ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 1 year ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 7, 2023, 11:08 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2023 Financial Results

Oct 10, 2023, 4:00 PM EDT - 1 year ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 18, 2023, 8:30 AM EDT - 1 year ago

Inogen Completes Acquisition of Physio-Assist

Sep 7, 2023, 8:30 AM EDT - 1 year ago

Inogen Announces CFO Transition Plan

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

Aug 7, 2023, 9:46 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Inogen Announces Second Quarter 2023 Financial Results

Aug 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators

Jul 18, 2023, 8:54 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

FGEN SILK THRX

Jul 13, 2023, 10:13 PM EDT - 2 years ago

Inogen: Still Struggling, But Very Cheap - Upgrading To Buy

Jul 13, 2023, 8:30 AM EDT - 2 years ago

Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist

May 15, 2023, 5:37 PM EDT - 2 years ago

Inogen to Present at 43rd Annual William Blair Growth Stock Conference

May 5, 2023, 6:34 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:05 PM EDT - 2 years ago

Inogen Announces First Quarter 2023 Financial Results

JarvisFlow Jun. 16 at 5:32 PM

B. Riley Securities has updated their rating for Inogen ( $INGN ) to Buy with a price target of 14.

0 · Reply

ZacksResearch May. 28 at 2:50 PM

0 · Reply

ZacksResearch May. 28 at 12:47 PM

0 · Reply

MoneyTree82 May. 27 at 2:38 PM

$INGN only 26 million share with improving revenues 💪

0 · Reply

ZacksResearch May. 27 at 1:12 PM

0 · Reply

ZacksResearch May. 27 at 12:12 PM

0 · Reply

RunnerSignals May. 22 at 9:39 PM

0 · Reply

Thestocktraderhubzee May. 22 at 4:02 PM

$INGN Inogen shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $12 price target.

0 · Reply

erevnon May. 22 at 11:22 AM

Needham upgrades Inogen $INGN from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow May. 22 at 10:30 AM

Needham updates rating for Inogen ( $INGN ) to Buy, target set at 12.

0 · Reply

Estimize May. 14 at 8:03 PM

Wall St is expecting -0.23 EPS for $INGN Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_c

0 · Reply

zecca1889 May. 8 at 2:33 PM

$INGN what happened if the accounts are fine?

0 · Reply

JarvisFlow Apr. 9 at 1:00 PM

Needham has adjusted their stance on Inogen ( $INGN ), setting the rating to Hold.

0 · Reply

Estimize Apr. 3 at 11:03 AM

Wall St is expecting -0.25 EPS for $INGN Q1 [Reporting 05/01 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_c

0 · Reply

Fugazi_ Mar. 31 at 7:43 PM

$INGN bought calls, somethings cookings

0 · Reply

zecca1889 Mar. 12 at 2:37 PM

$INGN https://www.zacks.com/stock/news/2428271/heres-why-you-should-retain-inogen-stock-in-your-portfolio-now?cid=CS-MKTWTCH-HL-analyst_blog|rank_focused-2428271&mod=mw_quote_news

0 · Reply

swingingtech Mar. 11 at 2:11 PM

$INGN $CAH $RMD $AVAH https://wallstreetwaves.com/top-reasons-to-keep-inogen-stock-in-your-investment-portfolio-today/

0 · Reply

redrussian Mar. 5 at 12:34 PM

$INGN 8.30 pre market

0 · Reply

d_risk Mar. 2 at 4:19 PM

$INGN - Inogen Inc Common Stock - 10K - Updated Risk Factors The 2025 10-K Risk Factors for INGN highlight intensified competition in the respiratory market, reliance on key customers, supply chain vulnerabilities, geopolitical and public health risks, regulatory compliance challenges, and increased ownership concentration, with new risks from international operations and third-party manufacturers. #Risk https://d-risk.ai/INGN/10-K/2025-02-28

1 · Reply

JarvisFlow Feb. 27 at 11:19 AM

Needham has updated their rating for Inogen ($INGN) to Hold.

0 · Reply

zecca1889 Feb. 26 at 5:21 PM

$INGN The accounts exceed expectations and the stock collapses. Are you drying?

0 · Reply

briefingcom Feb. 26 at 1:05 PM

Gapping up: $PRCH +24.8% $EYE +21.4% $GTM +19.1% $COMM +18.1% $INGN +15.6%

0 · Reply

Market Cap	168.04M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.69%
Debt to Equity Ratio	0.00

Volume	443,146
Avg Vol	276,254
Day's Range	N/A - N/A
Shares Out	26.89M
Stochastic %K	4%
Beta	1.64
Analysts	Sell
Price Target	$10.50